Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Corbel

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Expert Review of Vaccines|December 1, 2009
Prospects for new plague vaccinesValentina A Feodorova, Michael J Corbel
Expert Review of Vaccines|February 6, 2004
Toxicity and potency evaluation of pertussis vaccinesMichael J Corbel, Dorothy K L Xing
Veterinary Microbiology|November 5, 2002
Brucellosis vaccines: past, present and futureGerhardt G Schurig, Nammalwar Sriranganathan, Michael J Corbel
Expert Review of Vaccines|December 20, 2008
Current progress with Moraxella catarrhalis antigens as vaccine candidatesFatme Mawas, Mei Mei Ho, Michael J Corbel
Expert Review of Vaccines|October 7, 2009
Vaccines and biosimilarity: a solution or a problem?Michael J Corbel, Maria de Los Angeles Cortes Castillo
The Journal of Infectious Diseases|December 14, 2004
Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat modelFatme Mawas, Gareth Newman, Samantha Burns, et al.
Human Vaccines|October 3, 2006
Tuberculin purified protein derivative (PPD) immunoassay as an in vitro alternative assay for identity and confirmation of potencyMei M Ho, Satnam K Kairo, Michael J Corbel
Human Vaccines|October 3, 2006
Development of an approach for the laboratory toxicological evaluation of Bordetella pertussis adenylate cyclase genetic toxoid constructs as multipurpose vaccinesSandra Prior, Michael J Corbel, Dorothy K L Xing
Vaccine|November 9, 2010
Report of an International collaborative study to establish the first WHO reference reagents for BCG vaccines of three different sub-strainsMei M Ho, Kevin Markey, Peter Rigsby, et al.
Emerging Microbes & Infections|June 4, 2015
Russian vaccines against especially dangerous bacterial pathogensValentina A Feodorova, Lidiya V Sayapina, Michael J Corbel, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Expert Review of Vaccines|December 1, 2009
Prospects for new plague vaccinesValentina A Feodorova, Michael J Corbel
Expert Review of Vaccines|February 6, 2004
Toxicity and potency evaluation of pertussis vaccinesMichael J Corbel, Dorothy K L Xing
Veterinary Microbiology|November 5, 2002
Brucellosis vaccines: past, present and futureGerhardt G Schurig, Nammalwar Sriranganathan, Michael J Corbel
Expert Review of Vaccines|December 20, 2008
Current progress with Moraxella catarrhalis antigens as vaccine candidatesFatme Mawas, Mei Mei Ho, Michael J Corbel
Expert Review of Vaccines|October 7, 2009
Vaccines and biosimilarity: a solution or a problem?Michael J Corbel, Maria de Los Angeles Cortes Castillo
The Journal of Infectious Diseases|December 14, 2004
Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat modelFatme Mawas, Gareth Newman, Samantha Burns, et al.
Human Vaccines|October 3, 2006
Tuberculin purified protein derivative (PPD) immunoassay as an in vitro alternative assay for identity and confirmation of potencyMei M Ho, Satnam K Kairo, Michael J Corbel
Human Vaccines|October 3, 2006
Development of an approach for the laboratory toxicological evaluation of Bordetella pertussis adenylate cyclase genetic toxoid constructs as multipurpose vaccinesSandra Prior, Michael J Corbel, Dorothy K L Xing
Vaccine|November 9, 2010
Report of an International collaborative study to establish the first WHO reference reagents for BCG vaccines of three different sub-strainsMei M Ho, Kevin Markey, Peter Rigsby, et al.
Emerging Microbes & Infections|June 4, 2015
Russian vaccines against especially dangerous bacterial pathogensValentina A Feodorova, Lidiya V Sayapina, Michael J Corbel, et al.
Pageof 4